Robin L. Washington

2016

In 2016, Robin L. Washington earned a total compensation of $5.1M as Executive Vice President and Chief Financial Officer at Gilead Sciences, a 9% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$938,485
Option Awards$1,599,971
Salary$900,385
Stock Awards$1,619,221
Other$10,000
Total$5,068,062

Washington received $1.6M in stock awards, accounting for 32% of the total pay in 2016.

Washington also received $938.5K in non-equity incentive plan, $1.6M in option awards, $900.4K in salary and $10K in other compensation.

Rankings

In 2016, Robin L. Washington's compensation ranked 1,584th out of 14,075 executives tracked by ExecPay. In other words, Washington earned more than 88.7% of executives.

ClassificationRankingPercentile
All
1,584
out of 14,075
89th
Division
Manufacturing
538
out of 5,489
90th
Major group
Chemicals And Allied Products
152
out of 1,895
92nd
Industry group
Drugs
104
out of 1,538
93rd
Industry
Biological Products, Except Diagnostic Substances
20
out of 279
93rd
Source: SEC filing on March 26, 2018.

Washington's colleagues

We found four more compensation records of executives who worked with Robin L. Washington at Gilead Sciences in 2016.

2016

John Milligan

Gilead Sciences

Chief Executive Officer

2016

John Martin

Gilead Sciences

Chairman

2016

Norbert Bischofberger

Gilead Sciences

Chief Scientific Officer

2016

Kevin Young

Gilead Sciences

Chief Operating Officer

News

You may also like